Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gronseth, G. S.
Right arrow Articles by Barohn, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gronseth, G. S.
Right arrow Articles by Barohn, R. J.

Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review)

Report of the Quality Standards Subcommittee of the American Academy of Neurology

Gary S. Gronseth, MD and Richard J. Barohn, MD

From the American Academy of Neurology, St. Paul, MN.



View larger version (20K):

[in a new window]
  		Figure. (A–D) Relative rate of outcomes (with 95% confidence intervals) in patients with thymectomy compared with patients without thymectomy. (A) Relative rate medication-free remissions. (B) Relative rate asymptomatic. (C) Relative rate improvement. (D) Relative rate survival. Relative rates are plotted on a logarithmic scale. *Matched cohorts. Mid halftile = 25th to 50th percentiles.

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by AAN Enterprises, Inc.